Follow
Iona Gelabert
Iona Gelabert
senior technician
Verified email at crg.eu
Title
Cited by
Cited by
Year
Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains
A Kassan, A Herms, A Fernández-Vidal, M Bosch, NL Schieber, ...
Journal of Cell Biology 203 (6), 985-1001, 2013
3132013
The first-in-class anti-EGFR antibody mixture Sym004 overcomes cetuximab resistance mediated by EGFR extracellular domain mutations in colorectal cancer
FJ Sánchez-Martín, B Bellosillo, M Gelabert-Baldrich, A Dalmases, ...
Clinical Cancer Research 22 (13), 3260-3267, 2016
692016
Oncogenic K-ras segregates at spatially distinct plasma membrane signaling platforms according to its phosphorylation status
C Barceló, N Paco, AJ Beckett, B Alvarez-Moya, E Garrido, M Gelabert, ...
Journal of cell science 126 (20), 4553-4559, 2013
442013
Rac1 and Calmodulin Interactions Modulate Dynamics of ARF6‐Dependent Endocytosis
M Vidal‐Quadras, M Gelabert‐Baldrich, D Soriano‐Castell, A Lladó, ...
Traffic 12 (12), 1879-1896, 2011
362011
Dynamics of KRas on endosomes: involvement of acidic phospholipids in its association
M Gelabert‐Baldrich, D Soriano‐Castell, M Calvo, A Lu, A Viña‐Vilaseca, ...
The FASEB Journal 28 (7), 3023-3037, 2014
282014
Annexins and endosomal signaling
F Tebar, M Gelabert-Baldrich, M Hoque, R Cairns, C Rentero, A Pol, ...
Methods in Enzymology 535, 55-74, 2014
192014
Intradiploic epidermoid tumor of the occipital bone: X-ray, CT, MR findings
J Pumar, E Otero, A Castineira, M Alvarez, L Arrojo, M Gelabert, J Vidal
European Radiology 3, 183-185, 1993
101993
The anti-EGFR antibody mixture Sym004 overcomes acquired resistance to cetuximab in colorectal cancer
FJ Sanchez-Martin, A Dalmases, B Bellosillo, G Argiles, M Gelabert, ...
Cancer Research 76 (14_Supplement), 2149-2149, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–8